Blog Voices from the Frontlines
Patient-focused report graded medical marijuana programs. No states received an A. - Americans for Safe Access
By Bruce Kennedy for The Cannabist
Americans for Safe Access issues its annual state-by-state grades on medical cannabis laws and also calls on states to help combat the growing opioid crisis
None of the state medical marijuana laws adopted thus far in the U.S. can be considered ideal from a patient’s standpoint, and because of their patchwork nature, those laws do not function equitably and are often poorly designed, according to a new report by Americans for Safe Access.
The advocacy group’s new 2018 annual report, “Marijuana Access in the United States, A Patient-Focused Analysis of the Patchwork of State Laws,” evaluates every state with any medical marijuana laws on a 500-point scale.
Of the 46 states and three U.S. territories with some form of a medical marijuana program — covering about 95 percent of the country’s population — none received an “A” rating.
Sweet Releaf: The Latest Cannabis App Is Changing How Patients Receive Their Plant Knowledge - Americans for Safe Access
By Kelly Johnson for Big Buds
It’s amazing what can happen in just two years. The recent partnership announced between the cannabis app Releaf and the nonprofit Americans for Safe Access (ASA) is proof that patience, and dedication to the consumer, is a virtue in the green space.
“Americans for Safe Access has been an important champion for cannabis patients since 2002. [Releaf is] very excited to work with such a well-respected organization, and we’re honored that they recognize our sincere passion for empowering patients,” says Franco Brockelman, CEO and founder of Releaf.
The joint venture between the Washington, D.C.-based app and the longtime cannabis patient nonprofit organization will improve how users and dispensaries share cannabis knowledge, as well as the quality of medical data for researchers across America.
This week the United Nations (UN) Committee on Narcotic Drugs (CND) has their annual meetings in Vienna. The CND is responsible for implementing international drug control treaties as well as the scheduling of drugs. The CND makes decisions about scheduling new substances as well as changing the scheduling. The CND base these decisions on recommendations from the World Health Organization (WHO). The WHO makes their recommendations on the scheduling of drugs only after the Expert Committee on Drug Dependence (ECDD) prepares a critical review document.
Today’s agenda for the CND delegation includes the “Implementation of the international drug control treaties,” where they will discuss “changes in the scope of controlled substances” and “international cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion.”
This Week's Volunteer Needs
Please comment below if you are interested in helping, or if you have completed any of the following:
In the March 2018 Issue:
- ASA’s Annual States Report Finds Improvements
- DEA Removes More Misinformation from Website
- CBD Businesses Targeted in Tennessee, Charges Dropped
- ASA Partnering with Releaf App to Enhance Patient Services
- ASA Patient Education Course at Cannabis Learn Conference & Expo
- Tourette Association Symposium on Medical Cannabis Features ASA
- Scholarships Available for 2018 National Unity Conference
- Activist Profile: Ellen Lenox Smith, Rhode Island
- ACTION ALERT: Send the States Report to your Elected Officials
By Thomas Mitchell for Westword
Colorado used to to be one of the few states in the country with legal medical marijuana. But that has changed rapidly, with the majority of the states in the United States offering some kind of access to medical marijuana. According to a prominent advocacy group, however, many of those states put severe restrictions on MMJ, making Colorado's program look robust in comparison.
This week Americans for Safe Access released “Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws.” The report examines the status of states that have passed some form of medical marijuana laws and grades them on a 500 point scale based on how well their current law and regulations accommodate patient needs. The report reviews existing laws and regulations and laws passed in between January 1, 2017 and December 31, 2017, giving states letter grades from “A” to “F.” Unlike previous versions of this report, states are urged to begin to use medical cannabis as a tool to fight the opioid crisis in the areas of improvement section.
WASHINGTON, DC — February 28, 2018 — Today the medical cannabis advocacy organization, Americans for Safe Access, released its annual report entitled “Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws.” The report examines the status of states that have passed medical marijuana laws and grades them on a 500 point scale. Forty-six states and three territories have some form of medical cannabis program, meaning approximately 95% of the American population lives in a state with some form of medical cannabis law.
Americans for Safe Access Announces Partnership with Releaf App Aimed at Creating a New Class of Patient-Focused Dispensaries - Americans for Safe Access
Washington, D.C. - February 21, 2018 -- Today, Americans for Safe Access (ASA), a non-profit organization promoting safe and legal access to medical cannabis since 2002, and Releaf App, an experience tracking tool for cannabis patients, officially announced their partnership to empower medical cannabis patients and establish a new class of like-minded U.S. medical cannabis dispensaries.
In Virginia, cannabis oils – often referred to as medical marijuana – are only legal for those with epilepsy.
Even that legislation is relatively new – just a few years old. Advocates like Beth Collins with Americans for Safe Access and her 18-year-old daughter Jennifer are a major reason why the oils are even legal at all.
“I’m incredibly proud of the advocacy efforts of my daughter. Couldn’t be prouder.”
Jennifer has epilepsy. She and her mom moved to Colorado so she could experiment with alternative treatments for her illness.
She tried CBD oil, but that didn’t work, but then she tried THC-A oil, and it did.
“It’s great, you know. I’ve got my life back.”